Article
Melting the eis: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New eis Promoter Variants.
Antimicrobial agents and chemotherapy - 17 Jun 2021
Ley Serej D, Pillay Samantha, Streicher Elizabeth M, van der Heijden Yuri F, Sirgel Frederik, Derendinger Brigitta, de Kock Marianna, Gagneux Sébastien, Warren Robin M, Theron Grant, de Vos Margaretha
Abstract excerpt
Eis promoter mutations can confer reduced Mycobacterium tuberculosis kanamycin susceptibility. GenoType MTBDRsl, a widely used assay evaluating this region, wrongly classified 17/410 isolates as eis promoter wild type. Six out of seventeen isolates harbored mutations known to confer kanamycin resistance, and the remainder harbored either novel eis promoter mutations (7/11) or disputed mutations (4/11). GenoType...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
